What is OS Therapies Incorporated (OSTX) stock price today?

OS Therapies Incorporated (OSTX) currently trades at $1.70 per share. The stock has a market capitalization of $77.20M and a P/E ratio of —x.

Is OSTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, OS Therapies Incorporated has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -27.04.

Is OS Therapies Incorporated financially healthy?

OS Therapies Incorporated's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -27.04 places it in the distress.

OSTX

OS Therapies Incorporated

NYSE MKT: OSTX · HEALTHCARE · BIOTECHNOLOGY

$1.70

+4.29% today

Updated 2026-04-30

Market cap

$77.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.98

Dividend yield

—

52W range

$1 – $3

Volume

0.6M

Market cap

$77.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.98

Dividend yield

—

52W range

$1 – $3

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

3.3

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-27.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$10.89

+540.59%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -27.04 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-4.20M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-6.25M	$-7.79M	$-8.88M	$-28.75M	$-13.46M
EPS	—	—	—	—	$-0.98
Free cash flow	$-3.79M	$-3.01M	$-7.28M	$-14.24B	$-4.20M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OSTX	$77.20M	16	4.3	3.0	5.0	3.3	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

OS Therapies Incorporated trades at $1.70. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -27.04, it sits in the distress.

Frequently asked questions

What is OS Therapies Incorporated's stock price?

OS Therapies Incorporated (OSTX) trades at $1.70.

Is OS Therapies Incorporated overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of OS Therapies Incorporated (OSTX)?

The analyst target price is $10.89, representing +540.6% upside from the current price of $1.70.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-27.04 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNYSE MKT

CurrencyUSD

ostherapies.com

Quick metrics

P/S ratio—

ROE-914.00%

Beta—

50D MA$1.42

200D MA$1.71

Shares out0.04B

Float0.03B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

OSTX vs LLY →OSTX vs JNJ →OSTX vs ABBV →Stock screener →